Allison DeAngelis, mentioned 8 times across podcast episodes and expert conversations analyzed by Sonic.
Approximately 20% of obesity treatments currently in development are also being investigated for the treatment of the fatty liver disease MASH.
Zeeland Pharma and Boehringer Ingelheim announced a Phase 2 clinical trial success for a drug candidate in MASH.
Sanofi's most recent IV infusion product for Pompe disease is likely on patent until the early-to-mid 2030s.